No significant differences were detected in sex, age, ALT, ChildPugh, HBsAg, cirrhosis, portal hypertension, tumor number, tumor margin, rim enhancement, or peritumoral enhancement between the recurrence and non-recurrence groups (P>0.05). This evidence concerns the gene GPT and liver disorder.